R Squared LTD Theravance Biopharma, Inc. Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, R Squared LTD holds 19,976 shares of TBPH stock, worth $238,113. This represents 0.12% of its overall portfolio holdings.
Number of Shares
19,976
Previous 12,522
59.53%
Holding current value
$238,113
Previous $112 Million
97.04%
% of portfolio
0.12%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding TBPH
# of Institutions
138Shares Held
47.6MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$113 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$88.9 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$56.7 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$45.1 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$32.9 Million3.74% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $796M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...